探索Ceramide C16:0作为动脉样硬化症的新生物标志物和治疗标
Tingting Chen1,2,3, Lingling Xie1, Yan Zhao1
1The First School of Clinical Medicine Zhejiang Chinese Medical University Zhejiang Hangzhou China.
胺C16:0通过促进炎症和胰岛素抵抗,显著促进动脉样硬化. 针对这种脂代谢物提供了有前途的治疗策略,用于预防和治疗心血管疾病.
科学领域:
- 生物化学 生物化学
- 心血管科学 心血管科学
- 代谢学 代谢学 代谢学
背景情况:
- 脂,特别是胺C16:0,与代谢障碍有关.
- 动脉样硬化病原包括复杂的分子和细胞机制.
研究的目的:
- 审查胺C16:0在动脉样硬化中的致病作用.
- 为了探索胺C16:0作为预后生物标志物.
- 讨论针对陶胺C16:0.0的治疗策略.
主要方法:
- 临床前和临床研究的文献综述.
- 对将C16:0胺与动脉样硬化联系起来的分子机制的分析.
- 对血中胺C16:0水平和心血管事件的临床数据的评估.
主要成果:
- 胺C16:0激活炎症通路,诱导胰岛素抵抗,损害内皮功能,破坏线粒体平衡,并增加内质网膜应激.
- 血中胺C16:0水平升高与心血管事件风险有很强的相关性.
- 胺C16:0合成或受体阻断的抑制显示出治疗前景.
结论:
- 胺C16:0是动脉样硬化发展的关键调解剂.
- 血陶C16:0作为潜在的独立预后生物标志物用于心血管事件.
- 准胺C16:0通路为动脉样硬化提供了一个可行的治疗途径.
更多相关视频
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
08:01Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis
Published on: November 17, 2017
相关概念视频
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Lipid Catabolism
Atherosclerosis III: Management
Cholesterol: Significance and Regulation
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease I: Introduction
